The Business of Opioid Treatment | The Saving Dose Ep. 4

In the fourth episode of The Saving Dose, William Pedranti and Kendra Allen continue their conversation on the operational reality inside opioid treatment programs and get into the part of addiction recovery that almost nobody in the industry talks about publicly: what happens after the patient walks out the door, why most of them do not come back, and why the system was never designed to know the difference. This episode covers the economics of running an addiction treatment practice, why alcohol addiction is in many ways harder to treat than opioid addiction, how the shame and guilt cycle quietly destroys the clinical relationship, and what one text message from a counselor named Ashley revealed about how close patients can be to relapse without anyone knowing. In this episode: Why money is the single biggest barrier to addiction treatment in America, and why insurance coverage gaps mean that many people who need care most are the least able to access it. Why alcohol addiction may be harder to treat than opioid addiction, and what social acceptability has to do with it. The shame and guilt cycle: why patients who relapse between visits almost never tell their provider the truth, why that silence is a predictable system failure rather than a character flaw, and what a story about poppy seed muffins reveals about how broken the feedback loop is. What opioid treatment programs are actually up against: staffing shortages, burnout, Medicaid reimbursement pressure, patient churn, and a geography problem that puts clinics hours away from the patients who need them most. Alumni programs: what they are, why they matter, and why the story of Ashley texting a patient she had not spoken to in a year captures exactly what the gap between visits actually costs. How the addiction census grows in economic downturns, why designer drugs and animal tranquilizers are creating new crisis points in cities like Seattle, and what Kendra means when she says we are here to help the desperate. Where opioid treatment programs are headed, what the industry is trying to embrace, and why the providers who stay in this space are there for reasons that have nothing to do with the money. William's personal story: picking up a close friend's brother from a sober living facility after thirty days, and what it means when someone says recovery is sometimes day to day and sometimes minute to minute. About the Hosts John Hsu, MD is the Founder and CEO of iPill and a practicing anesthesiologist with 25 years in pain management and addiction medicine. He has taken multiple products through FDA approval and commercial launch. Connect with John:   / john-hsu-md-300a8b2a   William Pedranti is the COO of iPill, a Georgetown Law graduate, and co-founder of PENG Life Science Ventures. He has taken a biotech company from founding through FDA approval, commercial launch, and exit. Connect with William:   / williampedranti   Kendra Allen is the CRO of iPill with 20 years in behavioral health revenue strategy, payer contracting, and regulatory navigation. She founded and exited a national healthcare consulting firm. Connect with Kendra:   / kendra-allen-cro   Website: thesavingdose.com Disclaimer: This podcast is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any treatment decisions. #OpioidCrisis #AddictionRecovery #OpioidUseDisorder #MedicationAdherence #MOUD #BehavioralHealth #AddictionMedicine #OpioidTreatment #SubstanceUseDisorder #HealthcarePodcast #TheSavingDose #RecoveryPodcast #MentalHealth #PublicHealth #PatientRetention #MAT #AlcoholAddiction #OTPChallenges #PatientChurn #AddictionTreatment